A new research perspective was published in Oncotarget’s Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.”
Mainz Biomed Expands into Romania Through Partnership with Bioclinica – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 20.06.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed